Showing results (81-90 of 270) with videos related to
Sort By:
Pageof 27
CA: a Cancer Journal for Clinicians|July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease managementMaxime Borgeaud, Timothée Olivier, Jair Bar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2025
Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United StatesJoshua K Sabari, Helena A Yu, Parthiv J Mahadevia, et al.Clinical Lung Cancer|June 23, 2022
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short SurvivalFederico Cucchiara, Iacopo Petrini, Antonio Passaro, et al.Oncology|November 7, 2012
Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen moleculesDaniele Alesini, Roberto Iacovelli, Antonella Palazzo, et al.JCO Precision Oncology|June 18, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung CancerChristine M Lovly, Christina Baik, Misako Nagasaka, et al.Journal of Thoracic Disease|September 4, 2018
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative GroupTao Jiang, Chunxia Su, Shengxiang Ren, et al.European Journal of Cell Biology|June 24, 2009
Interaction of SH3P13 and DYDC1 protein: a germ cell component that regulates acrosome biogenesis during spermiogenesisShuchun Li, Yuan Qiao, Qian Di, et al.Current Oncology (Toronto, Ont.)|May 26, 2023
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.Stem Cells (Dayton, Ohio)|January 21, 2018
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem CellsMarzia Del Re, Elena Arrigoni, Giuliana Restante, et al.Journal of Clinical Medicine|March 11, 2023
Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung Cancer: A 20-Year Single-Center Retrospective StudyMonica Casiraghi, Francesco Petrella, Claudia Bardoni, et al.Pageof 27